In a study by Luo et al., the combination of mesenchymal stem cells (MSCs) with Gal-9 was found to improve survival rates and kidney function in mice with sepsis-associated acute kidney injury (SA-AKI) (69). This evidence concerns the gene LGALS9 and acute kidney injury.